title: Organization and regulation of the human rasGAP gene.
abstract: ras GTPase activating protein (rasGAP) is highly conserved among mammalian species and is required for normal cardiovascular system development. Expression of this protein exhibits both quantitative and qualitative variability among tissues. Using a combination of DNA sequencing and database analyses, we have determined that the human rasGAP gene spans 122 kb and is composed of 25 exons; the size of each intron and the intron/exon junctions also have been elucidated. With one exception, all intron/exon boundaries conform to the GT/AG rule; the splice donor site of intron 3 is GC/AG. Results of RNA ligase mediated rapid amplification of cDNA ends followed by sequence determination indicate that the transcription start point (TSP) is approximately 588 bp upstream from the translational start site and is uninterrupted by introns; this extremely long 5' untranslated region is continuous with the first coding exon. Analysis of 1 kb of sequence upstream of the TSP did not identify any of the typical promoter elements (TATA or CAAT boxes). Sequential deletions of this 1 kb region followed by secreted alkaline phosphatase reporter gene analysis revealed that transcription is supported by this region of the rasGAP gene. Because the highest efficiency is demonstrated by a 213 bp sequence just upstream from the TSP (-786 to -584), this region is identified as containing the rasGAP minimal promoter. Sequence analysis of this 213 bp sequence shows few candidate sites for transcription factor binding. A 406 bp fragment surrounding the TSP exhibits characteristics of a CpG island (68% C+G; observed/expected ratio of CpG=0.95). RapidScan analysis revealed that high levels of rasGAP transcript are present in placenta and testis, but transcript is not detectable in kidney and intestinal tract. These data suggest that rasGAP transcription is regulated by an atypical mechanism capable of producing quantitative variability among tissue types.
authors.affiliation: Department of Pharmacology, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Jason G
authors.initials: JG
authors.lastname: Glanzer
authors.forename: Lixin
authors.initials: L
authors.lastname: Liao
authors.forename: Tammy
authors.initials: T
authors.lastname: Baker
authors.forename: Mary H
authors.initials: MH
authors.lastname: McMullen
authors.forename: Amy S
authors.initials: AS
authors.lastname: Langan
authors.forename: Lisa Z
authors.initials: LZ
authors.lastname: Crandall
authors.forename: Roseann L
authors.initials: RL
authors.lastname: Vorce
mesh_terms: D000469:Alkaline Phosphatase / Q000235:genetics / Q000378:metabolism; D001483:Base Sequence; D018899:CpG Islands / Q000235:genetics; D004247:DNA / Q000737:chemistry / Q000235:genetics; D005091:Exons; D005260:Female; D005786:Gene Expression Regulation; D018507:Gene Expression Regulation, Developmental; D005796:Genes / Q000235:genetics; D006367:HeLa Cells; D006801:Humans; D007438:Introns; D008297:Male; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D017422:Sequence Analysis, DNA; D024363:Transcription Initiation Site; D014162:Transfection; D020703:ras GTPase-Activating Proteins / Q000235:genetics*
chemical_list: D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D020703:ras GTPase-Activating Proteins; D004247:DNA; D000469:Alkaline Phosphatase